促进者和障碍社区药房PrEP交付:一个范围审查
China Harrison1,2,3, Hannah Family1,2,3, Joanna Kesten1,2,3
1National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West), Bristol, UK.
Journal of the International AIDS Society
|March 18, 2024
概括
社区药房可以通过提供暴露前预防 (PrEP) 来改善艾滋病毒预防. 解决药剂师和客户的障碍和利用促进者是扩大PrEP获取的关键.
科学领域:
- 公共卫生 公共卫生
- 药房实践 在药房实践中
- 预防艾滋病毒 预防艾滋病毒
背景情况:
- 暴露前预防 (PrEP) 是预防艾滋病毒的高效药物.
- 在英国,PrEP可通过性健康诊所免费获得.
- 将PrEP服务扩展到社区药房符合英国的目标,即到2030年消除新的艾滋病毒病例.
研究的目的:
- 对社区药房口服PrEP供应的障碍和促进者的证据进行范围审查.
- 用能力,机会,动机,行为 (COM-B) 模型分析这些障碍和促进因素.
- 为提高PrEP在英国社区药房中的可访问性制定策略.
主要方法:
- 从创立到2023年8月,搜索了五个文献和五个评论数据库.
- 包括任何研究设计的文献,讨论社区药房PrEP交付的障碍和促进因素.
- 不包括试验登记,协议和新闻文章.
主要成果:
- 56项研究符合纳入标准,主要来自高收入环境,并在2020年后发表.
- 药剂师的障碍包括缺乏知识,培训,设施以及对成本和风险行为的担忧.
- 药剂师的促进因素包括培训,时间,设施,利潜力和减少艾滋病毒感染.
- 客户的障碍包括缺乏意识,药房设施不足以及将药剂师视为非医疗保健提供者.
- 客户方便者包括PrEP意识,药剂师培训,药房可访问性和个人兴趣.
结论:
- 鉴定的障碍和促进者需要对英国相关性进行探索,以优化PrEP交付.
- 在药房团队,客户和护理途径层面解决这些因素至关重要.
- 通过使用COM-B框架,社区药房可以在扩大PrEP可访问性和为艾滋病毒预防工作做出贡献方面发挥重要作用.
相关概念视频
Drug Delivery: Overview
292
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
292
Factors Influencing Drug Absorption: Pharmaceutical Parameters
134
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
134
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Drug Delivery: Enteral Route
439
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
439
Factors Influencing Drug Absorption: Presystemic Elimination
217
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
217
Drug Delivery: Parenteral Route
520
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
520


